Early prevention of left ventricular dysfunction after acute myocardial infarction (AMI) with angiotensin converting enzyme (ACE) inhibitors: A randomized control trial

1996 ◽  
Vol 49 ◽  
pp. S12
Author(s):  
V.L. Gupta ◽  
A.K. Mehra ◽  
H.R. Kulkarni
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Angiotensin Converting Enzyme ◽  
Ace Inhibitors ◽  
Randomized Control Trial ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Converting Enzyme ◽  
Early Prevention ◽  
Randomized Control

scholarly journals Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors

2010 ◽  
Vol 1 (1) ◽  
pp. 62-64
Author(s):  
A. S Galyavich
Keyword(s):  
Myocardial Infarction ◽  
Angiotensin Converting Enzyme ◽  
Ace Inhibitors ◽  
Ventricular Dysfunction ◽  
Enzyme Inhibitors ◽  
Angiotensin Converting Enzyme Inhibitors ◽  
Left Ventricular ◽  
Diabetic Patients ◽  
Converting Enzyme ◽  
Converting Enzyme Inhibitors

The paper analyzes the use of angiotensin-converting enzyme (ACE) inhibitors in patients after prior myocardial infarction. It presents the data of controlled studies, which indicate that it is warranted to use ACE inhibitors to improve prognosis in patients. It is concluded that it is unreasonable for a physician not to prescribe ACE inhibitors to post-myocardial infarction patients with obvious or asymptomatic left ventricular dysfunction and to diabetic patients (if no contraindications).

Sign in / Sign up

Export Citation Format

Share Document